Optinose Looking For A Partner To Optimize Big Opportunity In Chronic Sinusitis

 
• By Jessica Merrill

With positive Phase III data for its Xhance (fluticasone propionate) nasal spray in chronic sinusitis, Optinose believes it is poised to expand the target market for the drug 10-fold.

growth
Optinose eyes a big growth opportunity with new data • Source: Shutterstock

More from Sensory

More from Therapy Areas